40 results
424B5
ASLN
ASLAN Pharmaceuticals Ltd
12 Apr 24
Prospectus supplement for primary offering
8:15am
as our agents will not have any responsibility in respect of the validity or performance of delayed delivery contracts.
One or more firms, referred
424B5
ASLN
ASLAN Pharmaceuticals Ltd
14 Mar 24
Prospectus supplement for primary offering
6:24am
, you should not rely on it. We and the placement agent take no responsibility for, and can provide no assurance as to the reliability of, any other … such securities not sold for delayed delivery. The underwriters and other persons acting as our agents will not have any responsibility in respect
6-K
EX-10.1
qrgay3p3mp7xhvp
13 Mar 24
Aslan Pharmaceuticals Announces $5 Million Registered Direct Offering
7:27am
F-6EF
EX-99
ds4zwn56b rhgq
26 Apr 23
Automatic registration for ADRs (foreign)
5:26pm
424B5
y7gisq3106ue
13 Sep 22
Prospectus supplement for primary offering
4:05pm
6-K
EX-10.1
qryx14 f411gvllf
14 Jul 21
Current report (foreign)
6:04am
6-K
EX-1.1
km0 xvc9a1op4
4 Mar 21
Aslan Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
6:07am
424B5
zq7 ssuaoda
4 Mar 21
Prospectus supplement for primary offering
6:06am
424B5
3who124 v3pbc8vz
1 Mar 21
Prospectus supplement for primary offering
5:08pm
6-K
EX-99.2
szsdpdo4rqp0a7
1 Mar 21
Current report (foreign)
4:02pm
F-3/A
4fzm5 5q6
9 Feb 21
Shelf registration (foreign) (amended)
6:09am
F-3
esyol29
29 Jan 21
Shelf registration (foreign)
4:51pm
424B5
vtmj civb3b929rlfe0o
9 Oct 20
Prospectus supplement for primary offering
5:03pm
6-K
EX-99.1
1scv57x t5k0g4
9 Oct 20
Current report (foreign)
4:03pm
6-K
EX-99.5
2pogxree lql1xrphzks
9 Oct 20
Current report (foreign)
4:03pm